Showing 1,721 - 1,740 results of 2,192 for search '"Comorbidity', query time: 0.08s Refine Results
  1. 1721

    Uremic Leontiasis Ossea due to Resistant Secondary Hyperparathyroidism by Kubra Tuna, MD, Olesya Ilkun, MD, PhD, Peter T. Dziegielewski, MD, Anu Sharma, MD

    Published 2025-01-01
    “…It carries the risk of significant comorbidities due to cranial nerve compression, respiratory compromise, dysarthria, and dysphagia. …”
    Get full text
    Article
  2. 1722

    Maternal Serum Uric Acid as an Index of Perinatal Outcomes in Severe Preeclampsia by Rozhan Yassin Khalil, Awat Saber Muhammed

    Published 2018-07-01
    “…Included 100 pregnant women in third trimester with signs and symptoms of labour, who had no comorbid diseases. Grouped to 30 control without hypertension, 30 with pregnancy induced hypertension (PIH) and 40 with severe preeclampsia based on clinical and laboratory evaluation. …”
    Get full text
    Article
  3. 1723

    Intrapleural fibrinolytic therapy for pleural infections: Outcomes from a cohort study by Glenn Khai Wern Yong, Jonathan Jia Jun Wong, Xiaoe Zhang, Carmen Pei Sze Tan, Xiao Na Wang, Poh Seo Quek, Kim Hoong Yap

    Published 2024-12-01
    “…Data, including patient demographics; comorbidities; RAPID (renal, age, purulence, infection source and dietary factor) scores; and radiological characteristics, were extracted from medical records and analysed. …”
    Get full text
    Article
  4. 1724

    Assessing Psychosocial Burden in Psoriasis Patients Using the PRISM-RII Tool: A Comprehensive Evaluation by Elif Afacan Yıldırım, Muhterem Polat, Yusuf Ezel Yıldırım

    Published 2025-01-01
    “… Introduction: Psoriasis is a chronic, immune-mediated inflammatory disease that significantly impacts patients' quality of life due to its visible lesions and associated stigma. Psychological comorbidities are prevalent among psoriasis patients. …”
    Get full text
    Article
  5. 1725

    Evaluation of Insomnia Frequency, Beliefs and Attitudes Related Insomina in Primary Care by Zerrin Gamsýzkan, Selçuk Aslan

    Published 2014-12-01
    “…Of those 180 (78.4%) were female and 50 (21.6%) male patients. 92 female patients (40.1%) stated that they were menopausal period. 137 patients (%60) had comorbid chronic disease, and 93 patients (%40) had no chronic diseases. …”
    Get full text
    Article
  6. 1726
  7. 1727

    Assessing the Role of Emergency Physicians in Medical Clearance: Predictors of Diagnosing Psychiatric Illness in the Emergency Department – A Retrospective Cross-sectional Study by Ibrahim Khamis Abdullah Almamari, Darpanarayan Hazra, Awatif K. Alsarrai Al-Alawi

    Published 2025-01-01
    “…Notable findings involved family history or previous psychiatric illness (OR: 2.32; 95% CI: 0.59–6.09; P < 0.01), absence of medical comorbidities (adjusted OR: 2.47; 95% CI: 1.05–5.86; P < 0.01), and no new medication initiation before illness (OR: 6.43; 95% CI: 1.52–27.18; P < 0.01), normal sensorium (adjusted OR: 2.84; 95% CI: 0.81–10.00; P < 0.01) and intact orientation (adjusted OR: 6.73; 95% CI: 1.24–36.42; P < 0.01) demonstrated statistically significant predictors of an initial psychiatric diagnosis in the ED. …”
    Get full text
    Article
  8. 1728

    Development and validation of risk models to predict chronic kidney disease among people living with HIV: protocol for a systematic review by A P Kengne, Adesola Z Musa, Babatunde L Salako, Nasheeta Peer, Oluwatosin Olaseni Odubela, Nkiruka Odunukwe

    Published 2022-07-01
    “…This increased risk is attributed to HIV infection itself, antiretroviral therapy, coexisting viral infections, non-infectious comorbidities and traditional risk factors for CKD. Predictive models have been employed in the estimation of prevalent and incident CKD risk in both PLWH and the general population. …”
    Get full text
    Article
  9. 1729

    Dry eye disease and its treatment in women over 45 years by E.A. Drozdova, V.E. Balan

    Published 2021-05-01
    “…Additional factors of DED development in women are a high rate of comorbidities affecting gland functions, use of cosmetics and cosmetic procedures, contact lens wearing. …”
    Get full text
    Article
  10. 1730

    Re-presentations to the emergency department initial presentation with COVID-19: Insights from the omicron wave by Daniella Audish, George Braitberg, Anselm Wong

    Published 2025-03-01
    “…Additionally, 79 % of wave one patients and 29 % of wave two patients had respiratory-related comorbidities. Twelve percent of patients died within six months of the initial COVID-19 related presentation in wave one compared to 7 % in wave two. …”
    Get full text
    Article
  11. 1731

    Relationship between plasma uric acid levels, antioxidant capacity, and oxidative damage markers in overweight and obese adults: A cross-sectional study. by Natalia Albuja-Quintana, Aida M Chisaguano-Tonato, Maria E Herrera-Fontana, Sandra Figueroa-Samaniego, José M Alvarez-Suarez

    Published 2025-01-01
    “…Obesity, a complex metabolic chronic illness, is commonly accompanied by an excessive production of free radicals, which influences the development of its comorbidities. Uric acid is commonly linked to pro-oxidant effects on human health. …”
    Get full text
    Article
  12. 1732

    Preoperative Consultations and Their Effect on Surgical Delays and Mortality in Hip Fracture Surgery by Ekin Kaya Şimşek, Barış Kafa, Bahtiyar Haberal

    Published 2025-01-01
    “…Conclusion This study found that advanced age and high ASA scores were the main factors causing surgical delays in hip fracture patients. While modifiable comorbidities could reduce hospital stays, they did not significantly affect postoperative mortality. …”
    Get full text
    Article
  13. 1733

    Treatment of Multiple Sclerosis with Cladribine Tablets: Literature Review and the Guidance of the Lithuanian Association of Neurologists by R. Kizlaitienė, D. Mickevičienė, L. Malcienė, N. Giedraitienė, R. Balnytė, D. Jatužis

    Published 2024-03-01
    “…This makes cladribine convenient for patients with multiple comorbidities, difficulties in adhering to their prescribed treatment regimen, those planning a pregnancy, or those for whom long-term immunosuppression is undesirable. …”
    Get full text
    Article
  14. 1734

    “What women want”: Focus group discussions to inform the design of nutrition resources for women impacted by menopause following cancer treatment by Samantha J. Cushen, Micheala Murphy, Katie E. Johnston

    Published 2025-02-01
    “…Uncertainty related to dietary choices to manage menopausal symptoms can be distressing for female cancer survivors, potentially increasing the risk of developing comorbid conditions and reducing quality of life. The aim of this study was to assess the burden of menopausal symptoms, explore the nutritional information needs of cancer survivors and their preferences for the mode of delivery to inform future interventions on nutrition. …”
    Get full text
    Article
  15. 1735

    Amniotic Membrane as a Main Component in Treatments Supporting Healing and Patch Grafts in Corneal Melting and Perforations by Katarzyna Krysik, Dariusz Dobrowolski, Edward Wylegala, Anita Lyssek-Boron

    Published 2020-01-01
    “…All the procedures were evaluated, noting outcomes and complications of surgery, preoperative and postoperative visual acuities, postoperative intraocular pressures, graft rejection, and other late comorbidities and complications. Results. We performed 119 amniotic membrane applications (63%) and 70 corneal patch grafts (37%). …”
    Get full text
    Article
  16. 1736

    Diabetes Treatment with Dapagliflozin and Its Combinations: Insights from Clinical Practice by Akshay Bafna, Ajit Mehta, Rajeev Garg, Jayagopal Pathiyil Balagopalan, Rajesh Rajput, Nitin Zalte, Preethi Naik, Amarnath Sugumaran, Senthilnathan Mohanasundaram

    Published 2024-04-01
    “…The majority of clinicians opined that SGLT2i should be initiated in all T2DM patients with comorbidities to prevent HF complications (97.58%), and SGLT2i is underutilized in India for the treatment of HF in T2DM patients (89.21%). …”
    Get full text
    Article
  17. 1737

    Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis in Adult‐Onset Still's Disease: An Uncommon Initial Presentation in a Young Nepalese Female: A Case Repo... by Kanchan Bishwakarma, Kajal Bishwakarma, Sunil Bogati, Saket Jha

    Published 2025-01-01
    “…Here, we present a case of a 36‐year‐old Nepalese female, with no known comorbidities presented with a history of fever, sore throat, multiple joint pain, fluctuating rash, hair loss, and unintentional weight loss for a month. …”
    Get full text
    Article
  18. 1738
  19. 1739

    Prevalence, Awareness, Treatment, and Control of Hypertension and Its Associated Risk Factors: Results from Baseline Survey of SWADES Family Cohort Study by M. D. Saju, Komal Preet Allagh, Lorane Scaria, Shinto Joseph, Jotheeswaran Amuthavalli Thiyagarajan

    Published 2020-01-01
    “…The prevalence of hypertension was higher among persons with comorbidities (diabetes 64.5%, transient ischemic attack 54.7%, and heart disease 64.4%). …”
    Get full text
    Article
  20. 1740

    Intronic SNP in ESR1 encoding human estrogen receptor alpha is associated with brain ESR1 mRNA isoform expression and behavioral traits. by Julia K Pinsonneault, John T Frater, Benjamin Kompa, Roshan Mascarenhas, Danxin Wang, Wolfgang Sadee

    Published 2017-01-01
    “…In four GWAS cohorts, rs2104425 was significantly associated with behavioral traits, including: hypomanic episodes in female bipolar disorder subjects (GAIN bipolar disorder study; p = 0.0004), comorbid psychological symptoms in both males and females with attention deficit hyperactivity disorder (GAIN ADHD, p = 0.00002), psychological diagnoses in female children (eMERGE study of childhood health, subject age ≥9, p = 0.0009), and traits in schizophrenia (e.g., grandiose delusions, GAIN schizophrenia, p = 0.0004). …”
    Get full text
    Article